In the present retrospective study, the prophylactic use of antibiotics and G‐CSF was observed to be associated with a lower incidence of FN in patients with ESCC receiving neoadjuvant DCF therapy. This evidence concerns the gene CSF3 and esophageal squamous cell carcinoma.